The StitchCrew is seeking applications for FemHealth Accelerator.
Donor Name: StitchCrew
State: All States
County: All Counties
Type of Grant: Program
Deadline: 01/27/2023
Size of the Grant: $10,000
Details:
This program, run in collaboration with FemHealth Founders, an organization focused on cultivating a world-class femhealth ecosystem in the heartland, supports women entrepreneurs building technology-enabled, consumer-centric products and solutions that drastically improve women’s health and wellness.
Alongside StitchCrew, FHF and industry experts, participants will have the opportunity to refine and scale their approach to bringing women’s health and wellness products to market. Selected participants will receive a $10,000 non-dilutive grant and learn from Industry Executives, Capital Access Providers and other Thought Leaders in the space.
Focus Areas
Areas of interest include, but are not limited to:
- Personalized healthcare innovation
- Interoperable applications between physician and patient
- Real world evidence health data platforms
- Consumer solutions
- Wellness solutions
- Mental health solutions
Benefits Selected participants will receive:
A non-dilutive $10,000 stipend.
- Business Coaching from StitchCrew, FemHealth Founders, Investors, Executives as well as our extended network of business leaders.
- Weekly content to help you dive deep into relevant topics during group working sessions and one-on-one meetings.
- Community with other Founders. At the end the program participants will have the opportunity to showcase their products to investors, StitchCrew and FHF extended networks in Northwest Arkansas.
Criteria
They seek to engage early-stage women-owned companies in the FemHealth space building technology-enabled products and solutions that drastically improve women’s health and wellness. To be considered, applicants must:
- be women led
- be based in the U.S.
- be at least 18 years old at the time of application
Due to the extensive commercialization process and timeline, they are not focusing on biopharma, life-sciences products and incumbent medical devices requiring FDA approval.
For more information, visit FemHealth Accelator.
